{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:19:00Z","timestamp":1792088340012,"version":"4.4.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.jaci.2004.02.045","type":"journal-article","created":{"date-parts":[[2004,7,6]],"date-time":"2004-07-06T11:17:14Z","timestamp":1089112634000},"page":"3-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":133,"title":["Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non\u2013mast cell hematopoietic neoplasms"],"prefix":"10.1016","volume":"114","author":[{"given":"Peter","family":"Valent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang R","family":"Sperr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence B","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Horny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2004.02.045_BIB1","series-title":"Inflammatory mechanisms of allergic diseases","first-page":"3","article-title":"Mast cells and basophils","author":"Schwartz","year":"2002"},{"key":"10.1016\/j.jaci.2004.02.045_BIB2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0955-2235(91)90011-R","article-title":"The growth and differentiation of mast cells","volume":"3","author":"Valent","year":"1991","journal-title":"Prog Growth Factor Res"},{"key":"10.1016\/j.jaci.2004.02.045_BIB3","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI118337","article-title":"the alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis","volume":"96","author":"Schwartz","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.02.045_BIB4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000059404","article-title":"Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease","volume":"128","author":"Sperr","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000048184","article-title":"Surrogate markers of disease in mastocytosis","volume":"127","author":"Akin","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB6","doi-asserted-by":"crossref","first-page":"772","DOI":"10.4049\/jimmunol.148.3.772","article-title":"Effects of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells","volume":"148","author":"Kirshenbaum","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB7","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1182\/blood.V94.7.2333.419k30_2333_2342","article-title":"Demonstration that human mast cells arise from a progenitor cell population that is CD34+, c-kit+, and expresses aminopeptidase N (CD13)","volume":"94","author":"Kirshenbaum","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.02.045_BIB8","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.4049\/jimmunol.151.8.4221","article-title":"Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony forming cell","volume":"151","author":"Agis","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB9","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood.V84.8.2489.2489","article-title":"Mast cells cultured from peripheral blood of normal donors and patients with mastocytosis originate from a CD34+\/Fc\u03b5RI- cell population","volume":"84","author":"Rottem","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.02.045_BIB10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0167-5699(94)90153-8","article-title":"The riddle of the mast cell: c-kit ligand as missing link?","volume":"15","author":"Valent","year":"1994","journal-title":"Immunol Today"},{"key":"10.1016\/j.jaci.2004.02.045_BIB11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1073\/pnas.90.2.735","article-title":"Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand","volume":"90","author":"Mitsui","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2004.02.045_BIB12","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.V80.9.2237.2237","article-title":"Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor (SCF)\/kit ligand (KL) in long term culture","volume":"80","author":"Valent","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.02.045_BIB13","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.4049\/jimmunol.147.12.4224","article-title":"IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells","volume":"147","author":"Sillaber","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/blood.V52.2.447.447","article-title":"Decrease of mast cells in W\/Wv mice and their increase by bone marrow transplantation","volume":"52","author":"Kitamura","year":"1978","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.02.045_BIB15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1182\/blood.V53.3.492.492","article-title":"Decreased production of mast cells in Sl\/Sld mice","volume":"53","author":"Kitamura","year":"1979","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.02.045_BIB16","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of the c-kit product","volume":"92","author":"Furitsu","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2004.02.045_BIB17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000048179","article-title":"Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts","volume":"127","author":"Feger","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB18","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2004.02.045_BIB19","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng0396-312","article-title":"Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm","volume":"12","author":"Longley","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2004.02.045_BIB20","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-kit catalytic domain mutations in distinct forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2004.02.045_BIB21","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1046\/j.1523-1747.1998.00414.x","article-title":"Identification of activating c-kit mutations in adult-, but not childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behaviour","volume":"111","author":"Buttner","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0301-472X(99)00145-9","article-title":"Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis","volume":"28","author":"Akin","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2002-01-0203","article-title":"Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single cell analysis of mutations in the c-kit gene","volume":"100","author":"Yavuz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.02.045_BIB24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0145-2126(01)00041-8","article-title":"Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis","volume":"25","author":"Sperr","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2004.02.045_BIB25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1034\/j.1600-065X.2001.790108.x","article-title":"Variable expression of activation-linked surface antigens on human mast cells in health and disease","volume":"179","author":"Valent","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2004.02.045_BIB26","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.4049\/jimmunol.159.6.2911","article-title":"Effect of recombinant human IL-4 on tryptase, chymase, and Fc epsilon receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells","volume":"159","author":"Xia","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB27","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1046\/j.1365-2222.2002.01373.x","volume":"32","author":"Shimizu","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2004.02.045_BIB28","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1182\/blood.V73.7.1778.1778","article-title":"Mast cell typing: demonstration of a distinct hemopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes","volume":"73","author":"Valent","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.02.045_BIB29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0065-2776(08)60879-2","article-title":"Cell surface structures on human basophils and mast cells: biochemical and functional characterization","volume":"52","author":"Valent","year":"1992","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2141.1986.tb04133.x","article-title":"Mast cell leukemia: evidence for bone marrow origin of the pathological clone","volume":"64","author":"Dalton","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB31","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","article-title":"Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implication","volume":"91","author":"Escribano","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.02.045_BIB32","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1182\/blood.V98.13.3784","article-title":"Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells","volume":"98","author":"Schernthaner","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.02.045_BIB33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0145-2126(01)00050-9","article-title":"Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis","volume":"25","author":"Escribano","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2004.02.045_BIB34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000057747","article-title":"Detection of novel CD antigens on the surface of human mast cells and basophils","volume":"127","author":"Ghannadan","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1053\/hupa.2001.24319","article-title":"Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117\/Kit, and bcl-xL","volume":"32","author":"Jordan","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jcp.56.8.575","article-title":"Increase of bone marrow lymphocytes in systemic mastocytosis: reactive lymphocytosis or malignant lymphoma? Immuno-histochemical and molecular findings on routinely processed bone marrow biopsy specimens","volume":"56","author":"Horny","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0344-0338(85)80184-9","article-title":"Tissue mast cells in health and disease","volume":"179","author":"Parwaresch","year":"1985","journal-title":"Path Res Pract"},{"key":"10.1016\/j.jaci.2004.02.045_BIB38","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1111\/1523-1747.ep12468882","article-title":"Classification and diagnosis of mastocytosis: current status","volume":"96","author":"Metcalfe","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB39","first-page":"385","article-title":"Biology, classification and treatment of human mastocytosis","volume":"108","author":"Valent","year":"1996","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.jaci.2004.02.045_BIB40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2141.2003.04575.x","article-title":"Diagnosis and treatment of systemic mastocytosis: state of the art","volume":"122","author":"Valent","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0145-2126(01)00044-3","article-title":"Clinical and histopathological aspects of cutaneous mastocytosis","volume":"25","author":"Wolff","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2004.02.045_BIB42","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0145-2126(01)00021-2","article-title":"Diagnosis of mastocytosis: General histopathological aspects, morphological criteria, and immunohistochemical findings","volume":"25","author":"Horny","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2004.02.045_BIB43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000048180","article-title":"Histopathological and immunophenotypical aspects of mastocytosis","volume":"127","author":"Horny","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB44","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/1097-0142(19920715)70:2<459::AID-CNCR2820700214>3.0.CO;2-4","article-title":"Spleen findings in generalized mastocytosis. A clinicopathologic study","volume":"70","author":"Horny","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.jaci.2004.02.045_BIB45","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2559.1992.tb00428.x","article-title":"Lymph node findings in generalized mastocytosis","volume":"21","author":"Horny","year":"1992","journal-title":"Histopathology"},{"key":"10.1016\/j.jaci.2004.02.045_BIB46","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/1097-0142(19890201)63:3<532::AID-CNCR2820630322>3.0.CO;2-F","article-title":"Liver findings in generalized mastocytosis. A clinicopathologic study","volume":"63","author":"Horny","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.jaci.2004.02.045_BIB47","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.1111\/1523-1747.ep12469022","article-title":"The liver, spleen, and lymph nodes in mastocytosis","volume":"96","author":"Metcalfe","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB48","first-page":"4","article-title":"Pathology of the lymph node and spleen in systemic mast cell disease","volume":"1","author":"Travis","year":"1988","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB49","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/archderm.1963.01590140008002","article-title":"The natural course of urticaria pigmentosa","volume":"87","author":"Caplan","year":"1963","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB50","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0145-2126(01)00023-6","article-title":"Slowly progressing mastocytosis with high mast cell burden and no evidence of a non-mast cell hematologic disorder: an example of a smoldering case?","volume":"25","author":"Akin","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2004.02.045_BIB51","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0145-2126(01)00019-4","article-title":"A case of smouldering mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val","volume":"25","author":"Jordan","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2004.02.045_BIB52","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0145-2126(01)00172-2","article-title":"A case of smouldering mastocytosis with peripheral blood eosinophilia and lymphadenopathy","volume":"26","author":"Hauswirth","year":"2002","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2004.02.045_BIB53","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/mp.53.4.188","article-title":"Detection of c-kit mutation Asp-816-Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukemia","volume":"53","author":"Sotlar","year":"2000","journal-title":"Mol Pathol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000048185","article-title":"Smouldering mastocytosis: a new type of systemic mastocytosis with slow progression","volume":"127","author":"Valent","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB55","series-title":"Tumours of haematopoietic and lymphoid tissues. Vol 1. World Health Organization","first-page":"291","article-title":"Mastocytosis (mast cell disease). World Health Organization (WHO) classification of tumours. Pathology and genetics","author":"Valent","year":"2001"},{"key":"10.1016\/j.jaci.2004.02.045_BIB56","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0889-8588(03)00089-3","article-title":"Mast cell proliferative disorders: current view on variants recognized by the World Health Organization","volume":"17","author":"Valent","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaci.2004.02.045_BIB57","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2141.1990.tb07870.x","article-title":"Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders","volume":"76","author":"Horny","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB58","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/0002-9343(91)90214-I","article-title":"Hematologic manifestation of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis","volume":"91","author":"Lawrence","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2004.02.045_BIB59","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/10428190009058500","article-title":"Clinical and biologic diversity of leukemias occurring in patients with mastocytosis","volume":"37","author":"Sperr","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaci.2004.02.045_BIB60","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/1097-0142(19880901)62:5<965::AID-CNCR2820620520>3.0.CO;2-M","article-title":"Significance of systemic mast cell disease with associated hematologic disorders","volume":"62","author":"Travis","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.jaci.2004.02.045_BIB61","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal. Conference Report of Year 2000 Working Conference on Mastocytosis","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2004.02.045_BIB62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000024214","article-title":"Recent advances in mastocytosis research","volume":"120","author":"Valent","year":"1999","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB63","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/00000478-199809000-00013","article-title":"Diagnostic utility of staining for tryptase in patients with mastocytosis","volume":"22","author":"Horny","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB64","first-page":"982","article-title":"Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD68, myeloperoxidase, lysozym, and CD20 antibodies","volume":"9","author":"Li","year":"1996","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB65","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0145-2126(01)00029-7","article-title":"Diagnosis of mastocytosis: value of cytochemistry and immunohistochemistry","volume":"25","author":"Li","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2004.02.045_BIB66","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0145-2126(01)00020-0","article-title":"Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders","volume":"25","author":"Schwartz","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2004.02.045_BIB67","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0145-2126(01)00028-5","article-title":"Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy","volume":"25","author":"Longley","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2004.02.045_BIB68","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ajcp\/75.1.34","article-title":"Increased bone marrow mast cells in preleukemic syndromes, acute leukemia, and lymphoproliferative disorders","volume":"75","author":"Prokocimer","year":"1981","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB69","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0145-2126(01)00040-6","article-title":"Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2004.02.045_BIB70","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/10428190290012065","article-title":"Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): histopathologic and morphologic evaluation with special reference to novel SM-criteria","volume":"43","author":"Jordan","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaci.2004.02.045_BIB71","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.thj.6200164","article-title":"Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells","volume":"3","author":"Valent","year":"2002","journal-title":"Hematol J"},{"key":"10.1016\/j.jaci.2004.02.045_BIB72","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1056\/NEJM199202273260912","article-title":"Systemic mastocytosis","volume":"326","author":"Austen","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.02.045_BIB73","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0145-2126(02)00168-6","article-title":"Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria","volume":"27","author":"Valent","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2004.02.045_BIB74","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0025-6196(12)62636-6","article-title":"Mast cell leukemia: report of a case and review of the literature","volume":"61","author":"Travis","year":"1986","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaci.2004.02.045_BIB75","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000048187","article-title":"Cutaneous mastocytosis\u2014clinical heterogeneity","volume":"127","author":"Hartmann","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB76","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00277-002-0575-z","article-title":"Mastocytosis: current concepts in diagnosis and treatment","volume":"81","author":"Escribano","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB77","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000048188","article-title":"Mastocytosis: mediator-related signs and symptoms","volume":"127","author":"Castells","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB78","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0889-8588(05)70301-4","article-title":"Treatment of systemic mast cell disorders","volume":"14","author":"Worobec","year":"2000","journal-title":"Hematol Oncol North Am"},{"key":"10.1016\/j.jaci.2004.02.045_BIB79","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood.V98.7.2200","article-title":"Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia","volume":"98","author":"Sperr","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.02.045_BIB80","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM198706253162603","article-title":"Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis","volume":"316","author":"Schwartz","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.02.045_BIB81","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00062752-200401000-00009","article-title":"Clinical, genetic, and therapeutic insights into systemic mast cell disease","volume":"11","author":"Tefferi","year":"2004","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB82","unstructured":"Wimazal F, Schwarzmeier J, Sotlar K, Simonitsch I, Sperr WR, Fritsche-Polanz R, et al. Splenic mastocytosis: report of two cases and detection of the transforming c-kit mutation D816V. Leuk Lymphoma. In press."},{"key":"10.1016\/j.jaci.2004.02.045_BIB83","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jcp.39.6.596","article-title":"Mast cell sarcoma of the larynx","volume":"39","author":"Horny","year":"1986","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB84","first-page":"739","article-title":"Mast cell sarcoma with tissue eosinophilia arising in the ascending colon","volume":"12","author":"Kojima","year":"1999","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB85","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00043426-200102000-00014","article-title":"Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy","volume":"23","author":"Guenther","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB86","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1080\/10428190290021470","article-title":"Serum tryptase measurements in patients with myelodysplastic syndromes","volume":"43","author":"Sperr","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaci.2004.02.045_BIB87","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1046\/j.1365-2141.2002.03944.x","article-title":"Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients","volume":"119","author":"Casassus","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB88","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM199202273260907","article-title":"Response to interferon alfa-2b in a patient with systemic mastocytosis","volume":"326","author":"Kluin-Nelemans","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.02.045_BIB89","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2133.1995.tb08689.x","article-title":"Interferon-alpha in combination with corticosteroids improves systemic mast cell disease","volume":"132","author":"Delaporte","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB90","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/10428199609054789","article-title":"Treatment of three patients with systemic mastocytosis with interferon alpha-2b","volume":"22","author":"Worobec","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaci.2004.02.045_BIB91","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00663015","article-title":"Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b","volume":"72","author":"Weide","year":"1996","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB92","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1365-2133.1998.02131.x","article-title":"Response of severe systemic mastocytosis to interferon alpha","volume":"138","author":"Butterfield","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB93","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0145-2126(03)00259-5","article-title":"Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature","volume":"28","author":"Hauswirth","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2004.02.045_BIB94","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJM200101253440415","article-title":"Treatment of systemic mast-cell disease with cladribine","volume":"344","author":"Tefferi","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2004.02.045_BIB95","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1182\/blood-2003-05-1699","article-title":"Cladribine therapy for systemic mastocytosis","volume":"102","author":"Kluin-Nelemans","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.02.045_BIB96","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0145-2126(02)00073-5","article-title":"Cladribine induces immunophenotypical changes in bone marrow mast cells from mastocytosis. Report of a case of mastocytosis associated with a lymphoplasmacytic lymphoma","volume":"26","author":"Escribano","year":"2002","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2004.02.045_BIB97","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.leukres.2003.09.004","article-title":"Treatment of systemic mast cell disease: beyond interferon","volume":"28","author":"Tefferi","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2004.02.045_BIB98","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0301-472X(03)00112-7","article-title":"Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit","volume":"31","author":"Akin","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jaci.2004.02.045_BIB99","article-title":"A novel form of mastocytosis associated with a transmembrane c-Kit mutation and response to imatinib","author":"Akin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.02.045_BIB100","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.onc.1206120","article-title":"Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms","volume":"22","author":"Zermati","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jaci.2004.02.045_BIB101","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood-2003-05-1627","article-title":"CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy","volume":"102","author":"Pardanani","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2004.02.045_BIB102","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2141.2001.02783.x","article-title":"Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis","volume":"113","author":"Fritsche-Polanz","year":"2001","journal-title":"Br J Haematol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674904010772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674904010772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:53:31Z","timestamp":1758776011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674904010772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0091674904010772"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2004.02.045","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non\u2013mast cell hematopoietic neoplasms","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2004.02.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}